Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics

Journal of Psychiatric Research

Volumn 44, Issue 16, 2010, Pages 1158-1162

  Kohlrausch, Fabiana B ^a   Salatino Oliveira, Angélica ^a   Gama, Clarissa S ^a   Lobato, Maria Inês ^a   Belmonte de Abreu, Paulo ^a   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Clozapine; HTTLPR rs25531; Pharmacogenetics; Schizophrenia; Serotonin; Stin2

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BRAZIL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE; TREATMENT RESPONSE;

EID: 78649705744     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.04.003     Document Type: Article

References (48)

1. Abramson J.H., Gahlinger P.M. Computer programs for epidemiologists: PEPI. Version 4.0 2001, Sagesbrush Press, Salt Lake City.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, text revision, American Psychiatric Press, Washington DC. 4th ed.
3. Arranz M.J., Bolonna A.A., Munro J., Curtis C.J., Collier D.A., Kerwin R.W. The serotonin transporter and clozapine response. Molecular Psychiatry 2000, 5:124-125.
4. Arranz M.J., Munro J., Birkett J., Bolonna A., Mancama D., Sodhi M., et al. Pharmacogenetic prediction of clozapine response. Lancet 2000, 355:1615-1616.
5. Arranz M.J., de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 2007, 12:707-747.
6. Azevedo M.H., Soares M.J., Coelho I., Dourado A., Valente J., Macedo A., et al. Using consensus OPCRIT diagnoses. an efficient procedure for best-estimate lifetime diagnoses. British Journal of Psychiatry 1999, 175:154-157.
7. Azevedo M.H.P., Macedo A., Dourado A., Valente J., Coelho I., Soares M.J. Grupo de estudos de genetica psiquiatrica: uma decada de atividades. Psiquiatria Clínica 2000, 21:13-22.
8. Basile V.S., Masellis M., Potkin S.G., Kennedy J.L. Pharmacogenomics in schizophrenia: the quest for individualized therapy. Human Molecular Genetics 2002, 11:2517-2530.
9. Bozina N., Medved V., Kuzman M.R., Sain I., Sertic J. Association study of olanzapine induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients. J Psychopharmacol 2007, 21:728-734.
10. Brazilian Health Ministry Protocolo clínico e diretrizes terapêuticas: esquizofrenia refratária. Brasília: Portaria n° 2002, 345.
11. Chung C., Remington G. Predictors and markers of clozapine response. Psychopharmacology 2005, 179:317-335.
12. de Leon J. The future (or lack of future) of personalized prescription in psychiatry. Pharmacological Research 2009, 59:81-89.
13. Dolzan V., Serretti A., Mandelli L., Koprivsek J., Kastelic M., Plesnicar B.K. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1562-1566.
14. Elkis H., Meltzer H.Y. Refractory schizophrenia. Revista Brasileira de Psiquiatria 2007, 29:S41-S47.
15. Fan J.B., Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Molecular Psychiatry 2005, 10:928-938.
16. Gelernter J., Cubells J.F., Kidd J.R., Pakstis A.J., Kidd K.K. Population studies of polymorphisms of the serotonin transporter protein gene. American Journal of Medical Genetics 1999, 88:61-66.
17. Gil A., Gama C.S., de Jesus D.R., Lobato M.I., Zimmer M., Belmonte-de-Abreu P. The association of child abuse and neglect with adult disability in schizophrenia and the prominent role of physical neglect. Child Abuse Negligency 2009, 33:618-624.
18. Gupta S., Jain S., Brahmachari S.K., Kukreti R. Pharmacogenomics: a path to predictive medicine for schizophrenia. Pharmacogenomics 2006, 7:31-47.
19. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. Journal Neurochemistry 1996, 66:2621-2624.
20. Henna-Neto J., Elkis H. Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study. Revista Brasileira de Psiquiatria 2007, 29:228-232.
21. Hu X., Zhu G., Lipsky R., Goldman D. HTTLPR allele expression is codominant, correlating with gene effects on fMRI and SPECT imaging intermediate phenotypes, and behavior. Biological Psychiatry 2004, 55:191S.
22. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics 2006, 78:815-826.
23. Ito K., Yoshida K., Sato K., Takahashi H., Kamata M., Higuchi H., et al. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. Psychiatry Research 2002, 111:235-239.
24. Kaiser R., Tremblay P.B., Schmider J., Henneken M., Dettling M., Muller-Oerlinghausen B., et al. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Molecular Psychiatry 2001, 6:179-185.
25. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988, 45:789-796.
26. Kohlrausch F.B., Salatino-Oliveira A., Gama C.S., Lobato M.I., Belmonte-de-Abreu P., Hutz M.H. G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics. Pharmacogenomics 2008, 9:1429-1436.
27. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 1991, 19:5444.
28. Lee H.Y., Kim D.J., Lee H.J., Choi J.E., Kim Y.K. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients. Progress in Neuropsychopharmacol Biological Psychiatry 2009, 33:276-280.
29. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29:1062-1073.
30. MacKenzie A., Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proceedings of the National Academy of Sciences USA 1999, 96:15251-15255.
31. Malhotra A.K., Murphy G.M., Kennedy J.L. Pharmacogenetics of psychotropic drug response. The American Journal of Psychiatry 2004, 161:780-796.
32. Masellis M., Basile V.S., Ozdemir V., Meltzer H.Y., Macciardi F.M., Kennedy J.L. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine. Biological Psychiatry 2000, 47:252-266.
33. McGuffin P., Farmer A. Polydiagnostic approaches to measuring and classifying psychopathology. American Journal of Medical Genetics 2001, 105:39-41.
34. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reability of the OPCRIT system. Archives of General Psychiatry 1991, 48:764-770.
35. Murphy D.L., Lerner A., Rudnick G., Lesch K.P. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Molecular Interventions 2004, 4:109-123.
36. Ni X., Chan K., Bulgin N., Sicard T., Bismil R., McMain S., et al. Association between serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research 2006, 40:448-453.
37. Overall J.F., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
38. Reynolds G.P., Templeman L.A., Godlewska B.R. Pharmacogenetics of schizophrenia. Expert Opinion on Pharmacotherapy 2006, 7:1429-1440.
39. Santos N.P.C., Ribeiro-Rodrigues E.M., Ribeiro-dos-Santos A.K.C., Pereira R., Gusmão L., Amorim A., et al. Assessing individual interethnic admixture and population substructure using a 48 insertion/deletion ancestry-informative marker panel. Human Mutation 2010, 31:184-190.
40. Schumacher J., Schulze T.G., Wienker T.F., Rietschel M., Nothen M.M. Pharmacogenetics of the clozapine response. Lancet 2000, 356:506-507.
41. Soares M.J., Dourado A., Macedo A., Valente J., Coelho I., de Azevedo M.H.P. Estudo de fidelidade da lista de criterios operacionais para doencas psicoticas. Psiquiatria Clínica 1997, 18:11-24.
42. Tsai S.J., Hong C.J., Yu Y.W., Lin C.H., Song H.L., Lai H.C., et al. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia Research 2000, 44:177-181.
43. Vázquez-Bourgon J., Arranz M.J., Mata I., José María Pelayo-Terán J.M., Pérez-Iglesias R., Medina-González L., et al. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis. Psychiatry Research 2010, 175:189-194.
44. Wang L., Yu L., He G., Zhang J., Zhang A.P., Du J., et al. Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neuroscience Letters 2007, 414:1-4.
45. World Health Organization The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines 1992, Geneva.
46. Wilffert B., Zaal R., Brouwers J.R. Pharmacogenetics as a tool in the therapy of schizophrenia. Pharmacy World & Science 2005, 27:20-30.
47. Zhou S.F., Di Y.M., Chan E., Du Y.M., Chow V.D., Xue C.C., et al. Clinical pharmacogenetics and potential application in personalized medicine. Current Drug Metabolism 2008, 9:738-784.
48. Zembrzuski V.M., Callegari-Jacques S.M., Hutz M.H. Application of an African ancestry index as a genomic control approach in a Brazilian population. Annals of Human Genetics 2006, 70:822-828.